-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M47DtTFl25C3ZKfh4KK1nh+VDUEB+52jkufe+OsY1gA40g75SsuhHmkO/stZHYaB dnsYUEbFjWVitOK2s9c6cA== 0001209191-10-015960.txt : 20100310 0001209191-10-015960.hdr.sgml : 20100310 20100310160056 ACCESSION NUMBER: 0001209191-10-015960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100308 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 BUSINESS PHONE: 914-347-4300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN RON CENTRAL INDEX KEY: 0001272354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50513 FILM NUMBER: 10670576 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 15 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-03-08 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001272354 COHEN RON 15 SKYLINE DRIVE HAWTHORNE NY 10532 0 1 0 0 President and CEO Common Stock 2010-03-08 4 M 0 19000 2.60 A 188884 D Common Stock 2010-03-08 4 S 0 19000 33.1502 D 169884 D Common Stock 2010-03-09 4 M 0 19000 2.60 A 188884 D Common Stock 2010-03-09 4 S 0 19000 33.7253 D 169884 D Employee Stock Option (right to buy) 2.60 2010-03-08 4 M 0 19000 2.60 D 2003-09-11 2013-09-11 Common Stock 19000 445317 D Employee Stock Option (right to buy) 2.60 2010-03-09 4 M 0 19000 2.60 D 2003-09-11 2013-09-11 Common Stock 19000 426317 D The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.12 to $33.18 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.48 to $34.00 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ Ron Cohen 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----